Abbott Laboratories is buying Visiogen, a privately held ophthalmic device company based in California. The $400 million deal should close during the fourth quarter. Abbott, based in Illinois, bought Advanced Medical Optics earlier this year. Visiogen markets the Synchrony intraocular lens for presbyopia in cataract patients; it has been available ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.